Newborn Screening
At National Path Lab (NPL), we offer advanced newborn screening to ensure early detection of serious yet treatable genetic, metabolic, and endocrine disorders. Early diagnosis allows for timely intervention, preventing complications and improving lifelong health outcomes.
Why Newborn Screening?
Why Newborn Screening?
Newborns appear healthy at birth, but some may have hidden disorders that can lead to severe complications if left undetected. Our comprehensive screening panel helps identify such conditions before symptoms appear, allowing for early medical care and treatment.
Our panel includes tests for critical disorders such as:
Prevents intellectual disability and growth issues.
Congenital Adrenal Hyperplasia (CAH): Prevents life-threatening adrenal crises.
Cystic Fibrosis (CF): Early treatment improves lung function and life expectancy.
Phenylketonuria (PKU): Prevents intellectual disability through dietary management.
Galactosemia: Prevents liver failure and sepsis through dietary modifications.
Biotinidase Deficiency: Prevents neurological and skin complications.
G6PD Deficiency: Helps manage risk of hemolysis (red blood cell breakdown).
How is the Test Done?
How is the Test Done?
A few drops of blood are collected from the baby’s heel within 24-72 hours of birth. The sample is tested using advanced biochemical and molecular techniques. Results are analyzed by expert pathologists for accurate interpretation. If an abnormal result is detected, parents are informed immediately for further confirmatory testing and medical guidance.
